Plain-English translation of NCT07161479 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing two different endoscopic (camera-based) methods for treating small gastric adenomas with low-grade dysplasia—precancerous growths in the stomach lining that have a low risk of becoming cancer. Researchers want to compare argon plasma coagulation (APC), a technique that uses ionized gas to burn away the tissue, with endoscopic mucosal resection (EMR), a technique that cuts out and removes the entire growth. By comparing these two approaches in people with small growths (1 cm or smaller), the trial aims to determine which method is safer, more effective, and more practical.
Doctors currently disagree about the best way to treat these small precancerous stomach growths—some guidelines recommend removing them completely, while others suggest just watching them carefully over time. This trial exists to find out whether the simpler, less invasive APC approach works just as well as the more complex EMR approach, which could make treatment easier and safer for patients.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive either argon plasma coagulation or endoscopic mucosal resection to treat your small stomach growth. Both procedures are performed through an endoscope (a thin, flexible camera inserted through your mouth) while you are sedated, so you will not feel pain during the procedure. The trial will monitor your recovery and outcomes after treatment to compare how well each method works and whether any complications occur.
AI-generated summary from trial data · Jul 6, 2026 · Not medical advice
South Korea